NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY

The present invention relates to a novel fused pyrimidine derivative which inhibits tyrosine kinase activity. A pharmaceutical composition comprising the novel compound of the present invention as an active ingredient prevents or treats cancers, tumors, inflammatory diseases, autoimmune diseases, or...

Full description

Saved in:
Bibliographic Details
Main Authors SUH, KWEE HYUN, KIM, MAENG SUP, KWAK, EUN JOO, CHA, MI YOUNG, LEE, JU YEON, KANG, SEOK JONG, JO, MYOUNG GI, KIM, MI RA, HA, TAE HEE, JEON, JI YOUNG, LEE, KWANG OK
Format Patent
LanguageEnglish
Korean
Published 20.05.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel fused pyrimidine derivative which inhibits tyrosine kinase activity. A pharmaceutical composition comprising the novel compound of the present invention as an active ingredient prevents or treats cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases.
Bibliography:Application Number: KR20140042459